Metraipolis › archive › dc_5941ef4696d3
[Disease-modifying therapy with lecanemab for early Alzheimer's dementia] — Europe PMC PMID:41052542
- Source
- Europe PMC (de)
- Original
- https://europepmc.org/article/MED/41052542
- DOI
- 10.1055/a-2681-4558
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T13:08:09.522Z
- SHA-256 of the archived text
390cd419375f8d69c2c7706fc06180eea57b129e2fbfb303fc280e5937b05d90- Stable URL of this page
https://metraipolis.com/documento/dc_5941ef4696d3
How to cite
[Disease-modifying therapy with lecanemab for early Alzheimer's dementia] — Europe PMC PMID:41052542 — Europe PMC (de), https://europepmc.org/article/MED/41052542 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5941ef4696d3 (Metraipolis archive dc_5941ef4696d3, sha256 390cd419375f8d69c2c7706fc06180eea57b129e2fbfb303fc280e5937b05d90)
BibTeX
@misc{dc5941ef4696d3,
title = {[Disease-modifying therapy with lecanemab for early Alzheimer's dementia] — Europe PMC PMID:41052542},
howpublished = {Europe PMC (de)},
url = {https://europepmc.org/article/MED/41052542},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5941ef4696d3; sha256 390cd419375f8d69c2c7706fc06180eea57b129e2fbfb303fc280e5937b05d90},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41052542. Agents can read the archived copy with the MCP tool read_document.